NO20076041L - Identifisering av HLA-A2-presenterte T-celleepitoper som er avledet fra onkofotalt antigen-umodent lamininreseptorprotein og anvendelser derav - Google Patents
Identifisering av HLA-A2-presenterte T-celleepitoper som er avledet fra onkofotalt antigen-umodent lamininreseptorprotein og anvendelser deravInfo
- Publication number
- NO20076041L NO20076041L NO20076041A NO20076041A NO20076041L NO 20076041 L NO20076041 L NO 20076041L NO 20076041 A NO20076041 A NO 20076041A NO 20076041 A NO20076041 A NO 20076041A NO 20076041 L NO20076041 L NO 20076041L
- Authority
- NO
- Norway
- Prior art keywords
- tumor
- present
- relates
- laminin receptor
- hla
- Prior art date
Links
- 102000002297 Laminin Receptors Human genes 0.000 title abstract 2
- 108010000851 Laminin Receptors Proteins 0.000 title abstract 2
- 210000001744 T-lymphocyte Anatomy 0.000 title 1
- 206010028980 Neoplasm Diseases 0.000 abstract 4
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 3
- 230000005975 antitumor immune response Effects 0.000 abstract 2
- 230000001024 immunotherapeutic effect Effects 0.000 abstract 2
- 238000000034 method Methods 0.000 abstract 2
- 239000000203 mixture Substances 0.000 abstract 2
- 229960005486 vaccine Drugs 0.000 abstract 2
- 208000002250 Hematologic Neoplasms Diseases 0.000 abstract 1
- 239000008186 active pharmaceutical agent Substances 0.000 abstract 1
- 239000000427 antigen Substances 0.000 abstract 1
- 102000036639 antigens Human genes 0.000 abstract 1
- 108091007433 antigens Proteins 0.000 abstract 1
- 201000011510 cancer Diseases 0.000 abstract 1
- 210000004027 cell Anatomy 0.000 abstract 1
- 210000002443 helper t lymphocyte Anatomy 0.000 abstract 1
- 238000009169 immunotherapy Methods 0.000 abstract 1
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4748—Tumour specific antigens; Tumour rejection antigen precursors [TRAP], e.g. MAGE
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Toxicology (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP05009095A EP1717245B1 (en) | 2005-04-26 | 2005-04-26 | T-cell epitopes from the oncofetal antigen-immature laminin receptor protein and medical uses thereof |
| PCT/EP2006/003888 WO2006114307A1 (en) | 2005-04-26 | 2006-04-26 | T-cell epitopes from the oncofetal antigen-immature laminin receptor protein and medical uses thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO20076041L true NO20076041L (no) | 2007-11-23 |
Family
ID=34935739
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20076041A NO20076041L (no) | 2005-04-26 | 2007-11-23 | Identifisering av HLA-A2-presenterte T-celleepitoper som er avledet fra onkofotalt antigen-umodent lamininreseptorprotein og anvendelser derav |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US7968097B2 (es) |
| EP (2) | EP1717245B1 (es) |
| JP (1) | JP4870751B2 (es) |
| CN (1) | CN101166759B (es) |
| AT (1) | ATE512160T1 (es) |
| AU (1) | AU2006239505B2 (es) |
| BR (1) | BRPI0610841A2 (es) |
| CA (1) | CA2606088C (es) |
| EA (1) | EA013598B1 (es) |
| ES (1) | ES2367643T3 (es) |
| NO (1) | NO20076041L (es) |
| NZ (1) | NZ563432A (es) |
| UA (1) | UA97092C2 (es) |
| WO (1) | WO2006114307A1 (es) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2003258081A1 (en) * | 2002-08-02 | 2004-02-23 | South Alabama Medical Sciences Foundation | Cancer vaccines containing epitopes of oncofetal antigen |
| US20090004213A1 (en) * | 2007-03-26 | 2009-01-01 | Immatics Biotechnologies Gmbh | Combination therapy using active immunotherapy |
| EA018457B1 (ru) * | 2007-07-27 | 2013-08-30 | Имматикс Байотекнолоджиз Гмбх | Композиция опухолеассоциированных пептидов и относящаяся к ним противораковая вакцина |
| PT2113253E (pt) * | 2008-04-30 | 2010-06-15 | Immatics Biotechnologies Gmbh | Formulações novas de peptídeos associados a tumores que se ligam a moléculas de classe i ou ii do antígeno leucocitário humano (hla) para vacinas |
| WO2010111671A1 (en) * | 2009-03-26 | 2010-09-30 | Quantum Immunologics, Inc. | Oncofetal antigen/immature laminin receptor antibodies for diagnostic and clinical applications |
| WO2011006084A2 (en) * | 2009-07-09 | 2011-01-13 | South Alabama Medical Science | Vaccines with oncofetal antigen/ilrp-loaded autologous dendritic cells and uses thereof |
| WO2011024791A1 (ja) * | 2009-08-25 | 2011-03-03 | タカラバイオ株式会社 | レチノイン酸存在下でのｔ細胞集団の製造方法 |
| EP2330122A1 (en) | 2009-12-02 | 2011-06-08 | Asklepios Kliniken Hamburg Gmbh | OFA/iLRP derived modified peptide |
| NL2014935B1 (en) | 2015-06-08 | 2017-02-03 | Applied Immune Tech Ltd | T cell receptor like antibodies having fine specificity. |
| EP4317432A3 (en) | 2016-12-08 | 2024-04-17 | Immatics Biotechnologies GmbH | T cell receptors with improved pairing |
| DE102016123893A1 (de) | 2016-12-08 | 2018-06-14 | Immatics Biotechnologies Gmbh | T-Zellrezeptoren mit verbesserter Bindung |
| BR112019020959A2 (pt) * | 2017-04-10 | 2020-05-05 | Immatics Biotechnologies Gmbh | peptídeos e combinações dos mesmos para uso na imunoterapia contra câncer |
| WO2018224166A1 (en) * | 2017-06-09 | 2018-12-13 | Biontech Rna Pharmaceuticals Gmbh | Methods for predicting the usefulness of disease specific amino acid modifications for immunotherapy |
| CN112512538A (zh) * | 2018-05-18 | 2021-03-16 | 国家儿童医疗中心 | 改进的靶向t细胞疗法 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2195642A1 (en) | 1994-07-27 | 1996-02-08 | Andreas Suhrbier | Polyepitope vaccines |
| ES2203782T3 (es) | 1996-01-17 | 2004-04-16 | Imperial College Innovations Limited | Inmunoterapia que utiliza linfocitos t citotoxicos (ctl). |
| US20040236091A1 (en) | 2001-03-28 | 2004-11-25 | Chicz Roman M. | Translational profiling |
| AU2003258081A1 (en) | 2002-08-02 | 2004-02-23 | South Alabama Medical Sciences Foundation | Cancer vaccines containing epitopes of oncofetal antigen |
| US20070224201A1 (en) | 2002-10-02 | 2007-09-27 | Genentech, Inc. | Compositions and methods for the diagnosis and treatment of tumor |
| US20070166318A1 (en) * | 2003-05-30 | 2007-07-19 | Macina Roberto A | Compositions, splice variants and methods relating to ovarian specific nucleic acids and proteins |
| US20080206270A1 (en) * | 2004-07-08 | 2008-08-28 | Minev Boris R | Enhancing Class I Antigen Presentation With Synthetic Sequences |
-
2005
- 2005-04-26 ES ES05009095T patent/ES2367643T3/es not_active Expired - Lifetime
- 2005-04-26 EP EP05009095A patent/EP1717245B1/en not_active Expired - Lifetime
- 2005-04-26 AT AT05009095T patent/ATE512160T1/de not_active IP Right Cessation
-
2006
- 2006-04-26 CN CN2006800141605A patent/CN101166759B/zh not_active Expired - Fee Related
- 2006-04-26 EA EA200702202A patent/EA013598B1/ru not_active IP Right Cessation
- 2006-04-26 EP EP06724593A patent/EP1874810A1/en not_active Ceased
- 2006-04-26 BR BRPI0610841-5A patent/BRPI0610841A2/pt not_active IP Right Cessation
- 2006-04-26 WO PCT/EP2006/003888 patent/WO2006114307A1/en not_active Ceased
- 2006-04-26 CA CA2606088A patent/CA2606088C/en not_active Expired - Fee Related
- 2006-04-26 NZ NZ563432A patent/NZ563432A/en not_active IP Right Cessation
- 2006-04-26 UA UAA200712736A patent/UA97092C2/ru unknown
- 2006-04-26 JP JP2008508151A patent/JP4870751B2/ja not_active Expired - Fee Related
- 2006-04-26 US US11/912,668 patent/US7968097B2/en active Active
- 2006-04-26 AU AU2006239505A patent/AU2006239505B2/en not_active Ceased
-
2007
- 2007-11-23 NO NO20076041A patent/NO20076041L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| ATE512160T1 (de) | 2011-06-15 |
| AU2006239505B2 (en) | 2012-05-10 |
| EP1874810A1 (en) | 2008-01-09 |
| CA2606088C (en) | 2015-05-26 |
| CN101166759A (zh) | 2008-04-23 |
| JP4870751B2 (ja) | 2012-02-08 |
| BRPI0610841A2 (pt) | 2010-07-27 |
| UA97092C2 (ru) | 2012-01-10 |
| US7968097B2 (en) | 2011-06-28 |
| EA013598B1 (ru) | 2010-06-30 |
| EA200702202A1 (ru) | 2008-04-28 |
| WO2006114307A1 (en) | 2006-11-02 |
| EP1717245A1 (en) | 2006-11-02 |
| US20090041794A1 (en) | 2009-02-12 |
| NZ563432A (en) | 2010-11-26 |
| JP2008538901A (ja) | 2008-11-13 |
| AU2006239505A1 (en) | 2006-11-02 |
| ES2367643T3 (es) | 2011-11-07 |
| CN101166759B (zh) | 2012-09-05 |
| EP1717245B1 (en) | 2011-06-08 |
| CA2606088A1 (en) | 2006-11-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20076041L (no) | Identifisering av HLA-A2-presenterte T-celleepitoper som er avledet fra onkofotalt antigen-umodent lamininreseptorprotein og anvendelser derav | |
| EA200800677A1 (ru) | Опухолеассоциированные пептиды, беспорядочно связывающиеся с молекулами класса ii человеческого лейкоцитарного антигена (hla) | |
| EA200800676A1 (ru) | Опухолеассоциированные пептиды, связывающиеся с молекулами человеческого лейкоцитарного антигена (hla) i или ii класса, и относящаяся к ним противораковая вакцина |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |